Robert Duggan
#272

Robert Duggan

United States 82 years old Self-Made

Overview

Source of Wealth
Pharmaceuticals
Industry
Healthcare
Residence
Miami, Florida
Education
University of California, Los Angeles (Drop Out)
University of California, Santa Barbara (Drop Out)
Marital Status
Married
Children
8

Assets

  • AbbVie Inc.
    3,795,000 shares @ -
    -
    ABBV-US
  • Akeso Inc
    8,343,000 shares @ -
    -
    9926-HK
  • Alphabet
    100 shares @ -
    -
    GOOGL-US
  • Citigroup
    50,000 shares @ -
    -
    C-US
  • Intuitive Surgical
    100 shares @ -
    -
    ISRG-US
  • Iovance Biother
    100 shares @ -
    -
    IOVA-US
  • JPMorgan Chase & Co.
    346,000 shares @ -
    -
    JPM-US
  • Microsoft
    2,000 shares @ -
    -
    MSFT-US
  • Newmont Mining
    200,000 shares @ -
    -
    NEM-US
  • Nvidia
    230 shares @ -
    -
    NVDA-US
  • Protagonist Therapeutics
    89,000 shares @ -
    -
    PTGX-US
  • Pulse BioSciences
    48,597,000 shares @ -
    -
    PLSE-US
  • Rivian
    245,000 shares @ -
    -
    RIVN-US
  • Summit Therapeutics
    520,000 shares @ -
    -
    SMMT-US
  • Summit Therapeutics
    200,000 shares @ -
    -
    SMMT-US
  • Summit Therapeutics
    555,755,000 shares @ -
    -
    SMMT-US
  • Summit Therapeutics
    4,795,000 shares @ -
    -
    SMMT-US
  • Voyager Therapeutics
    820,000 shares @ -
    -
    VYGR-US

Biography

In 2020, Robert Duggan invested $63 million in Nasdaq-listed Summit Therapeutics and became its Co-CEO, leading the biotech in developing targeted oncology therapies for difficult diagnoses.

Pharmacyclics' cancer drug Imbruvica made Duggan a billionaire in 2013 and paved the way for the company's $21 billion sale to AbbVie in 2015.

Duggan, whose son died from brain cancer, became passionate about Pharmacyclic's cancer fighting drugs and first invested in 2004.

His enthusiasm for investing began four decades earlier in a corporate finance class he took at the University of California at Santa Barbara.

In 2020, Duggan bought $63 million of shares in Nasdaq-listed Summit Therapeutics, a small biotech company, and became its CEO.

Duggan also sits on the board of Pulse Biosciences, of which he is the largest individual shareholder.

About

Duggan is a big donor to the Church of Scientology, of which he is a member; he says he's given the church nearly $360 million over his lifetime.

Duggan enjoys surfing in his spare time.